| Literature DB >> 9425622 |
K K Anand1, B Singh, A K Saxena, B K Chandan, V N Gupta, V Bhardwaj.
Abstract
Compound I isolated from fraction TB5 of Terminalia belerica and finally identified as 3,4,5-trihydroxy benzoic acid (gallic acid) was evaluated for its hepatoprotective activity against carbon tetrachloride (CCl4)-induced physiological and biochemical alterations in the liver. The main parameters studied were hexobarbitone-induced sleep, zoxazolamine induced paralysis, serum levels of transaminases and bilirubin. The hepatic markers assessed were lipid peroxidation, drug metabolising enzymes, glucose-6-phosphatase and triglycerides. Administration of Compound I led to significant reversal of majority of the altered parameters. Our results confirm the presence of hepatoprotective activity in altered parameters. Our results confirm the presence of hepatoprotective activity in Compound I.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9425622 DOI: 10.1006/phrs.1997.0236
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658